Emergent BioSolutions | Acreedores Comerciales



Trade Creditors Cambio Fecha
Acadia Pharmaceuticals USD 18.1M 1.9M 2025-03
ALKERMES USD 59.84M 14.21M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amarin USD 45.66M 5.3M 2025-03
ANI Pharmaceuticals USD 53.06M 7.4M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Exact Sciences USD 142.17M 52.6M 2025-03
Exelixis USD 42.84M 4.65M 2025-04
Glaxosmithkline 3.46B 10.01B 2024-12
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
Ironwood Pharmaceuticals USD 2.13M 1.11M 2024-12
Lonza CHF 471M 3M 2024-12
Merck USD 3.78B 295M 2025-03
Moderna USD 226M 179M 2025-03
Myriad Genetics USD 28.1M 4.2M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
Pacira USD 23.17M 4.04M 2025-03
Pfizer USD 5.24B 393M 2025-03
PTC Therapeutics USD 15.15M 2.12M 2025-03
Sanofi 21.62B 14.07B 2025-03
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
United Therapeutics 6M 357.9M 2024-12



Emergent BioSolutions Acreedores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.